These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36045608)

  • 1. Dendritic cells generated from induced pluripotent stem cells and by direct reprogramming of somatic cells.
    Flosdorf N; Zenke M
    Eur J Immunol; 2022 Dec; 52(12):1880-1888. PubMed ID: 36045608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cells.
    Silk KM; Silk JD; Ichiryu N; Davies TJ; Nolan KF; Leishman AJ; Carpenter L; Watt SM; Cerundolo V; Fairchild PJ
    Gene Ther; 2012 Oct; 19(10):1035-40. PubMed ID: 22071967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of Human Induced Pluripotent Stem Cells (iPS Cells) and Embryonic Stem Cells (ES Cells) into Dendritic Cell (DC) Subsets.
    Sontag S; Förster M; Seré K; Zenke M
    Bio Protoc; 2017 Aug; 7(15):e2419. PubMed ID: 34541147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling IRF8 Deficient Human Hematopoiesis and Dendritic Cell Development with Engineered iPS Cells.
    Sontag S; Förster M; Qin J; Wanek P; Mitzka S; Schüler HM; Koschmieder S; Rose-John S; Seré K; Zenke M
    Stem Cells; 2017 Apr; 35(4):898-908. PubMed ID: 28090699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
    Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a High-Efficacy Reprogramming Method for Generating Human Induced Pluripotent Stem (iPS) Cells from Pathologic and Senescent Somatic Cells.
    Tanaka N; Kato H; Tsuda H; Sato Y; Muramatsu T; Iguchi A; Nakajima H; Yoshitake A; Senbonmatsu T
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32942642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical potential of human-induced pluripotent stem cells : Perspectives of induced pluripotent stem cells.
    Kumar D; Anand T; Kues WA
    Cell Biol Toxicol; 2017 Apr; 33(2):99-112. PubMed ID: 27900567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancements in reprogramming strategies for the generation of induced pluripotent stem cells.
    Lai MI; Wendy-Yeo WY; Ramasamy R; Nordin N; Rosli R; Veerakumarasivam A; Abdullah S
    J Assist Reprod Genet; 2011 Apr; 28(4):291-301. PubMed ID: 21384252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced pluripotent stem cells: a new approach for physiological research.
    Pfannkuche K; Hannes T; Khalil M; Noghabi MS; Morshedi A; Hescheler J; Dröge P
    Cell Physiol Biochem; 2010; 26(2):105-24. PubMed ID: 20798495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in reprogramming somatic cells to induced pluripotent stem cells.
    Patel M; Yang S
    Stem Cell Rev Rep; 2010 Sep; 6(3):367-80. PubMed ID: 20336395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of dendritic cells and macrophages from human induced pluripotent stem cells aiming at cell therapy.
    Senju S; Haruta M; Matsumura K; Matsunaga Y; Fukushima S; Ikeda T; Takamatsu K; Irie A; Nishimura Y
    Gene Ther; 2011 Sep; 18(9):874-83. PubMed ID: 21430784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential role for insulin-like growth factor signaling in induction of pluripotent stem cell formation.
    Li Y; Geng YJ
    Growth Horm IGF Res; 2010 Dec; 20(6):391-8. PubMed ID: 20956084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced Pluripotent Stem Cells from Cancer-Resistant Naked Mole-Rats.
    Miura K; Oiwa Y; Kawamura Y
    Adv Exp Med Biol; 2021; 1319():329-339. PubMed ID: 34424523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells.
    Tat PA; Sumer H; Jones KL; Upton K; Verma PJ
    Cell Transplant; 2010; 19(5):525-36. PubMed ID: 20144262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct reprogramming of rat neural precursor cells and fibroblasts into pluripotent stem cells.
    Chang MY; Kim D; Kim CH; Kang HC; Yang E; Moon JI; Ko S; Park J; Park KS; Lee KA; Hwang DY; Chung Y; Lanza R; Kim KS
    PLoS One; 2010 Mar; 5(3):e9838. PubMed ID: 20352099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of reprogramming ability of mouse ES and iPS cells measured by somatic cell fusion.
    Sumer H; Nicholls C; Liu J; Tat PA; Liu JP; Verma PJ
    Int J Dev Biol; 2010; 54(11-12):1723-8. PubMed ID: 21404192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cells: emerging techniques for nuclear reprogramming.
    Han JW; Yoon YS
    Antioxid Redox Signal; 2011 Oct; 15(7):1799-820. PubMed ID: 21194386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells.
    Pan G; Wang T; Yao H; Pei D
    Bioessays; 2012 Jun; 34(6):472-6. PubMed ID: 22419173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of human induced pluripotent stem cells derived from blood and other postnatal cell types.
    Ye Z; Cheng L
    Regen Med; 2010 Jul; 5(4):521-30. PubMed ID: 20632856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid and highly efficient generation of induced pluripotent stem cells from human umbilical vein endothelial cells.
    Panopoulos AD; Ruiz S; Yi F; Herrerías A; Batchelder EM; Izpisua Belmonte JC
    PLoS One; 2011; 6(5):e19743. PubMed ID: 21603572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.